Philippe Motté
Gründer bei Celestial Consulting & Coaching
Aktive Positionen von Philippe Motté
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Celestial Consulting & Coaching | Gründer | 01.06.2018 | - |
Präsident | 01.06.2018 | - | |
Académie nationale de Pharmacie | Corporate Officer/Principal | - | - |
Karriereverlauf von Philippe Motté
Ehemalige bekannte Positionen von Philippe Motté
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENFIT | General Counsel | 01.06.2020 | 01.08.2022 |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.05.2019 | 01.06.2020 |
GENSIGHT BIOLOGICS S.A. | General Counsel | 12.09.2022 | - |
Ausbildung von Philippe Motté
ESCP Europe Campus London | Masters Business Admin |
Université Paris-Saclay | Doctorate Degree |
Universite Paris Cite | Doctorate Degree |
Statistik
International
Frankreich | 8 |
Vereinigtes Königreich | 2 |
Operativ
General Counsel | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENFIT | Health Technology |
GENSIGHT BIOLOGICS S.A. | Health Technology |
Private Unternehmen | 3 |
---|---|
Celestial Consulting & Coaching | |
Académie nationale de Pharmacie | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Philippe Motté
- Erfahrung